Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013825 |
---|---|
Receipt number | R000016135 |
Scientific Title | Expiratory randomized phase II trial for optimizing treatment dose and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer |
Date of disclosure of the study information | 2014/04/28 |
Last modified on | 2022/03/16 13:24:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/28 10:30:31 | ||
2 | Update | 2014/10/31 12:42:01 | Primary outcomes Key secondary outcomes |
|
3 | Update | 2014/10/31 12:42:47 | Name of person sending information Name of person sending information |
|
4 | Update | 2015/05/08 11:45:27 | Recruitment status |
|
5 | Update | 2015/10/13 18:28:28 | Acronym Acronym |
|
6 | Update | 2015/10/13 18:55:35 | Organization Organization Division name Division name Address Address TEL Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Institutions |
|
7 | Update | 2015/10/13 18:56:47 | Recruitment status |
|
8 | Update | 2015/10/14 16:31:03 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL |
|
9 | Update | 2018/05/01 09:16:58 | Recruitment status |
|
10 | Update | 2019/11/05 10:40:00 | Number of participants that the trial has enrolled |
|
11 | Update | 2019/11/05 10:42:20 | Date of IRB Last follow-up date |
|
12 | Update | 2020/11/02 09:56:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
13 | Update | 2021/11/02 09:32:06 | Name of person sending information Name of person sending information Address Address TEL |
|
14 | Update | 2022/03/16 13:24:16 | Organization Organization Address Address TEL Organization1 Address1 Tel1 Email1 |